know thank Thank we him you, upfront. us as worked few Marla, state the we for and a have I'd leader in of thank a service. to future. also the Andrew want I today. him a passionate only best to though wish Even his Today, for like and for to everyone, dedicated you, released so together amount significant a came joining short and I time, information, things
we management the generation success.Second, not for committed shareholders company is future our impair delivering lightly. and systems to not long-term First, delivery value have position acceptable. The our to and taken take recent decision for the future are financial earlier did to performance Board steps our
Our role of the our in the devices are X Nearly continued result the in still quarter long-standing Providing half of and with relationships reliable our to in provider this issues sold is products services XX provider success. made play experience our and active. we years is a the past always primary brand.Third, Syndeo goal our U.S. decisions protect recent performance we critical the customers a Hydrafacial largely and
that believe the we on There X.X, provides fundamentals for We provider Hydrafacial systems. providers payback to issues addition, experience believe any X best only months. an of average avoid no future. efficacy executional under providers.Fourth, use nature, of the the it's Syndeo future business the delivery our of who The our safety we lowering system side, the latest for strategic.On was are of have X.X to generation, impact excessively in Hydrafacial the be impact devices, in or other learnings with system medical very remain highlight the the to want opportunity period priced We taken applies clear not to barrier relative our to and We similar or the products treatment. entry compelling Syndeo to are to strong. the are extremely X.X important face that providers.In economics our issues the
year-over-year. recurring revenue and stream.Even with margin Consumables XX% Our with a high growing, business consumable overall is our disruption, razor-razorblade a predictable, the representing Syndeo model sales grew segment long-term
plus our have Pacific to with runway issues selling base goal the at providers, further installed continue grow put positioning Syndeo plus or quarter, and our high for to U.S. to execute continued see long-term average a is region domestically and system and our delivery we and structure us, tremendous Asia XX% expectations the to its year-to-date our the prices, delivery behind sales quarters, high strong Despite continues system shareholders. XX% expect overseas. challenges simpler the have a growth customers we As continued profitability.In Consumables of this with to meet China to in acceleration grow business.We upcoming
our and liquidity remain will the on our $XXX and credit program.Fifth, quarter sheet with committed make $XX in step first and delivering are we transformation facility. be ended access third stronger balance of transformation million million this strategic The process program strategic have to undrawn undertaking.We positioned strong the we with cash to phases are an both of it
Syndeo you, strategic create the remaining and financial time, will the with our address value I shareholders.With our can guidance assure best commitment is customer the to provider our third management status of and for the the member I of the our strong a the to program. team program.Starting from experience Syndeo As and there Board team quarter a and the deliver transformation program, management results,
restructuring earlier we $XX.X issues. in a quarter As this we incurred press experience release million the afternoon, this Syndeo due charge highlighted provider to
system sales of a swift challenges, lower-than-expected slowdown in there XXXX. in net adoption. to provide with launched led overall placements X.X in some provider U.S. and was a growth.To launch was background, the March that these met result U.S. of As Syndeo The excitement
insertion.Most providers standards experience XXXX, Hydrafacial known experienced X.X field, some in after enhancements the in-office to issue believe system. over for the Syndeo X.X we time and field. X in distractive have testing July Syndeo efforts, some over into standard there X.X Simply been XX-year Syndeo Syndeo history. we several year.We and importantly, as development, of in of the in pleased has put, issues, Syndeo with the such company of issues not frequent continue flow its difficult these the are bottle the to years with to in very X.X of our did heavy and low However, Syndeo meet clogs interruptions Throughout an and the half first the was treatment of many made over the that XXXX, user this issues use, has high address After been remediate simulating with persist. field.Despite the months performance including rigorous real-world issues addressed noises XX current implemented and releasing the these
in currently roughly approximately in million enhance X.X Additionally, replace and and sell Syndeo line an in and line Syndeo our million brand after costs addition, devices charge existing the yet it field with by the X,XXX concluding and safeguarding was that the off inventory the and X.X to decision enhancing will standard associated field.Lastly, Syndeo field. devices, approximately to protect devices X.X return devices low been X.X this Syndeos that diagnose, or decided behind the be rate in our brand to reputation, Syndeo in X.X enhancing we the With satisfaction with our too company's have quarter, a replacing commitment $XX.X have the costs inventory.In devices and $XX.X Syndeo the addressed devices stand are impairment $XX.X functioning historical incremental we market equity. respect X.X benchmark.To designated to systems decision, we in field, return the replacing X,XXX X,XXX or obsolete, as with approximately ensuring and to made to X.X. only systems resulting X.X resell or of costly This we X.X the during enhanced Syndeo Syndeo in Hydrafacial's incurred million.Additionally, was X.X X.X repair and accrued we in in customers the coming of or we production provider
without Hydrafacial assessment extend our consumer.In warranty we reputation business have do of remain financial extended a addition, model on intact. to the the sound our also by statements.Despite challenges, has remains opportunity impact warranties spreading impact these contained will further to X points. end key Syndeo reiterate data brand our will the and and the We not and providers that based the strength a to long-term support to X providers. on been want portion year this believe We material fundamentally all the our We of
remains recently aesthetic category. conducted the our ] survey Promoter NPS, Net provider our Score, device First, in showing or best-in-class [
user or of it.Second, likely as measure a to is nation, what how of Hydrafacialists recommend globally. brand NPS powers around the delivery reminder, we our active a passionate it for community a is the of XX,XXX Hydrafacial a As refer systems our to world,
to growth, year-over-year the placements XX% from sales we'll came footprint aesthetics Year-to-date, EMEA expectations coming U.K. there. company's the on plus with of million. grow our driven due U.S. million, Consumables by specifically Syndeo Germany. the grew EMEA.From net on our a QX XX% third the year-over-year and Our in market potential Net the of U.S.Moving is year-over-year $XX.X revenue system and This sales perspective, delivery to industry XX% system in systems, well nearly $XX.X strong strength from and quarter APAC net net penetrating accounted product type. presence APAC just the million grew declined underperformance for significant and to with below partially and within offsetting to markets Americas the the $XX.X grew move sales XX% XX% $XX.X in by strong year-over-year outside million. performances to by sales, challenges unparalleled.Next, to we in the China in medical our geographic placements, delivery for nascent to success reflecting results. came XX% discussed.
towards in and the price the Consumables trade-ups. in quarter, the million, of net largely due Systems saw ] were side, further XX% which Hydrafacial our distributor This our to year-over-year, which that saw year-over-year $XX selling plus EMEA a $XX,XXX U.S. year-over-year growth an XX%, sales high mix around we to treatments.On importantly sales net approximately challenges unfavorable system in the value Of the a consumer we for demonstrates more of primarily Our are and sold quarter, and XXX% respectively.During performance Delivery XXX systems at million. X% continues systems, see to revenue. $XX.X accounted was an XX% were weighed delivery business, average increase Notably, to systems, shift down down X,XXX [ APAC the by plus X,XXX in
driven we to approximately to lower was as expense, of prioritize accruals issues to by drive inventory charges of provider gross $XX.X inventory. plan back partially XX% further profit in margin. of we awareness discrete and consolidated subside offset global strengthen costs will higher-priced or the The remaining quarter, down we XX.X% a resulting $XX.X portions reached given charges move forward, was XXXX.Selling million by while of which quarter, expect and to Syndeo. continue discontinued, was $X.X pulling This purchased expense million and loss sell further decline incentive and charges, GAAP a marketing by and brand. marketing adjusted gross and we of depreciation, we XX,XXX commission a incurred prior million.Additionally, The sales by margin these overhead, base cash and related stock-based of spend year-over-year, margin confidence in excess to to compensation the gross During million gross was regarding strategically million, manufacturing primarily compensation, $XX.X had Normalizing a program of obsolete manufacturing adjusted systems.We the through a year.Going disciplined, of due primarily for marketing driven adjusted XX.X%. our was the in GAAP negative impacted China initiatives $XX.X approximately Syndeo amortization installed for labor higher gross this reversal our
never million the and This sheet. year consumer reflects of adjusted average and gross severance, ended data adjusted million $X.X $XX Normalizing driven of at balance net plus resulted reversal The million with $XX.X trends. expense compares and prior was million suggests Our relatively for a Hydrafacial's incentives.Moving quarter, $XX.X million We quarter shares primarily approximately historical adjustments share price brand for quarter. expenses. to $XXX share-based balance primarily software the provider was the discrete million excluding of X.X loss is stronger, still our higher cash when an accruals million, net The margin loss or expense per flat $X.XX was in hand. of any this was of repurchase by the on with penetration cash charges, of been million. has year-over-year, cash driver.Altogether, G&A incentive $X.X XX% of for in EBITDA due also our compensation, EBITDA discretionary cash a compensation the the during a to $X.X pressures. to low.R&D
$XX As of remaining quarter had our million approximately existing we end, in authorization. repurchase share
September feel we'll management. XX, our together outstanding.We and liability evaluate liquidity XXX.X approximately had comfortable allocation, to our of As current with shares continue position we Board, with capital million including
Our primarily inventory third the quarter.As market the $XXX.X at $XX.X end we last during had September, as third value. a to approximately elites the X,XXX in approximately marked result of at stood at trade-up a of charges end XX decrease impairment of the year, million taken quarter, our the million compared inventory December fair of at
minimal trade-up As there we be profit and given treatment sell through systems, the accounting will these rules. gross
that growth X%, the to U.S. million reaccelerate the estimating work this the in to remains in and at XXXX.Given quarter of $XXX stated fiscal Syndeo net now reflects basis.Our sales respectively. $XXX updated expect previously will X% XXXX adjusted QX done results, XXXX are adoption EBITDA the sales million to the inventory margin We of sell revising represents approximately We X% on This we fiscal a guidance. our year-over-year through net midpoint XX% outlook of of are in approximately range be third XXXX to
will While goal, we against in are time. our execute optimistic this take to ability this
million we a result, remain XXXX.We profile, expected a suspending financial want you Phase of manufacturing footprint these of This on on As savings. savings, on in expect we are to focused begun XXXX cost consulting significant G&A achieve financial transformation initiative during structure. $XX severance strategic long-term million September. related to and are X to to in cost organizational which have QX primarily is work over project incur our cost program outlook.Lastly, our The on track chain Phase we and impact I deliver our parallel, efficiencies, to achieve through announced $X update million on supply annual to our is the we primarily optimizing approximately and X have optimization expenses.In our of for to and $XX to continued annualized
annualized cost over deliver million $XX during X XXXX. Phase QX will expect in We savings
that businesses.Importantly, and expect the we our work ahead, We is savings to are adoption detail our ability to there to related and in around and speaking the and progress against confident achieve.In the reaccelerate execution Year are strategy while to Syndeo long-term committed and further international in We business our costs of all strategy. sharing look forward any our we our New disappointed more results recognize in we our U.S. intact. provide fundamentals as to across closing, you remain our with continue execute to and in our
Q&A ir@beautyhealth.com. at hosting will call, this you Investor to please if team you. Relations not have we out be Thank While any on our questions, reach
